Smoking Cessation Treatment

Initiation and Dosage

Varenicline should be initiated 1-2 weeks before the target quit date, with a standard dosing schedule of 0.5 mg once daily for days 1-3, 0.5 mg twice daily for days 4-7, and then 1 mg twice daily for weeks 2-12 if tolerated, as recommended by the National Comprehensive Cancer Network 1
Gradual titration of varenicline helps minimize dose-related side effects, particularly nausea, which is the most common adverse event reported with varenicline therapy 1

The initial treatment duration for varenicline is 12 weeks, and extended treatment of an additional 12 weeks (total of 24 weeks) is recommended for successful quitters to increase the likelihood of long-term abstinence, as recommended by the National Comprehensive Cancer Network 1
Follow-up should be scheduled within 2-3 weeks after therapy begins, following 12 weeks of therapy, and at the end of therapy (if beyond 12 weeks), with a recommended frequency of four or more sessions during each 12-week course 1

Varenicline should always be combined with appropriate behavioral counseling to maximize success rates, including conducting a psychiatric history and suicide risk assessment before prescription due to potential neuropsychiatric side effects, as recommended by the European Heart Journal 2
Counseling sessions should be 10-30+ minutes per session, with longer and more frequent sessions linked to higher success rates, and may include individual or group therapy, in-person and/or by phone, or referral to a smoking cessation quitline 1
The "5 A's" approach (Ask, Advise, Assess, Assist, Arrange) is a national model for tobacco treatment in medical care, with evidence showing its effectiveness 3
Counseling content should include skills training for practical problem-solving, social support, motivational interviewing, and print or web-based educational materials, as well as problem-solving skills, coping strategies for nicotine withdrawal, identifying smoking triggers, and strategies for high-risk situations 1

Pregnant women should receive counseling as the first-line treatment, and if unsuccessful, consider short-acting NRT, as recommended by relevant guidelines 4
Hospitalized patients are an excellent opportunity to begin treatment with counseling and NRT 4
Smoking cessation should be prioritized before weight management, as smoking is an immediate cardiovascular risk factor, according to the American Heart Association 5
Patients with cardiovascular disease, COPD, and depression should prioritize smoking cessation, as it reduces overall mortality and improves health outcomes 6, 4, 5, 7

Varenicline, bupropion SR, and nicotine replacement therapy (NRT) are effective pharmacotherapies for smoking cessation, with varenicline being the most effective first-line treatment, achieving abstinence rates of approximately 28% compared to 12% with placebo, as recommended by the American College of Physicians 6
Combining pharmacotherapy with behavioral counseling significantly increases quit rates from approximately 8% to 14% compared to usual care or minimal interventions, as recommended by the American College of Physicians 6
Using two types of NRT is more effective than using a single type, according to the American College of Physicians, as published in the Annals of Internal Medicine 6

Inadequate treatment duration, inadequate dosing, failure to address both physical and psychological aspects of nicotine addiction, and not combining pharmacotherapy with behavioral support are common pitfalls in treatment, as identified by the American College of Physicians 6
Common challenges include insufficient duration of treatment, inadequate dosing, and not addressing both physical and psychological aspects of nicotine addiction, with side effects such as hiccups, heartburn, nausea, throat irritation, and mouth soreness 1
Monitor for potential neuropsychiatric symptoms, although the risk is low in patients without psychiatric history, according to the American College of Cardiology 4

E-cigarettes and other alternative methods have insufficient evidence for recommendation, according to the NCCN guidelines 1